The global market for arthropod-borne viral infections testing is projected to witness significant growth, reaching a valuation of US$ 1.9 billion by 2029. This growth, representing a Compound Annual Growth Rate (CAGR) of 5.6% from 2022, highlights the increasing demand for advanced diagnostic solutions in combating arboviral diseases worldwide. Arboviral diseases, caused by viruses transmitted …